HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $573 | +5.9% | 15 | 0.0% | 0.00% | – |
| Q2 2023 | $541 | -54.3% | 15 | -51.6% | 0.00% | – |
| Q1 2023 | $1,184 | -32.9% | 31 | 0.0% | 0.00% | – |
| Q4 2022 | $1,764 | +76.4% | 31 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 31 | +19.2% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 26 | -13.3% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 30 | -42.3% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 52 | +23.8% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 42 | -37.3% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +50.0% | 67 | -2.9% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 69 | +53.3% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 45 | -22.4% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 58 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 58 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |